ICU Medical (NASDAQ:ICUI) Shares Cross Above 200 Day Moving Average - Time to Sell?

Key Points

• ICU Medical shares rose above their 200-day moving average, reaching $164.15 and last trading at $161.24 versus the $149.89 average.
• Analyst sentiment remains positive, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $192.80; several firms recently raised their targets to between $187 and $200.
• The company exceeded quarterly earnings and revenue estimates, but insiders sold 21,830 shares worth approximately $3.9 million over the past three months.

Shares of ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $149.89 and traded as high as $164.15. ICU Medical shares last traded at $161.24, with a volume of 153,808 shares trading hands.

Analyst Ratings Changes

ICUI has been the subject of a number of recent research reports. Needham & Company LLC boosted their price objective on shares of ICU Medical from $165.00 to $187.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Weiss Ratings upgraded ICU Medical from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, October 8th. Piper Sandler increased their target price on ICU Medical from $163.00 to $195.00 and gave the company an "overweight" rating in a research report on Friday, August 7th. BTIG Research lifted their price target on ICU Medical from $170.00 to $200.00 and gave the company a "buy" rating in a report on Friday, August 7th. Finally, Wall Street Zen upgraded ICU Medical from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 8th. Two investment analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, ICU Medical currently has an average rating of "Moderate Buy" and an average price target of $192.80.

ICU Medical Price Performance

The firm has a market capitalization of $4.03 billion, a P/E ratio of 136.64, a P/E/G ratio of 2.05 and a beta of 0.86. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.43 and a quick ratio of 1.21. The stock's fifty day simple moving average is $167.15 and its 200 day simple moving average is $149.89.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 EPS for the quarter, beating the consensus estimate of $1.91 by $0.46. ICU Medical had a net margin of 1.39% and a return on equity of 7.91%. The business had revenue of $547.88 million during the quarter, compared to analyst estimates of $533.44 million. During the same period in the prior year, the firm posted $2.10 earnings per share. The company's quarterly revenue was up .5% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. On average, equities research analysts predict that ICU Medical, Inc. will post 7.22 EPS for the current year.

Insider Activity at ICU Medical

In other ICU Medical news, COO Christian Voigtlander sold 8,929 shares of ICU Medical stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $182.93, for a total value of $1,633,381.97. Following the transaction, the chief operating officer directly owned 37,377 shares of the company's stock, valued at approximately $6,837,374.61. The trade was a 19.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Virginia Sanzone sold 4,856 shares of the company's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $168.69, for a total value of $819,158.64. Following the transaction, the vice president directly owned 14,604 shares in the company, valued at approximately $2,463,548.76. The trade was a 24.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 21,830 shares of company stock valued at $3,905,003 over the last three months. Company insiders own 2.10% of the company's stock.

Institutional Trading of ICU Medical

A number of institutional investors have recently made changes to their positions in ICUI. Allworth Financial LP acquired a new position in ICU Medical during the 2nd quarter valued at about $26,000. Versant Capital Management Inc raised its stake in ICU Medical by 26.2% in the third quarter. Versant Capital Management Inc now owns 313 shares of the medical instruments supplier's stock valued at $50,000 after buying an additional 65 shares during the last quarter. Hilton Head Capital Partners LLC raised its stake in ICU Medical by 52.0% in the first quarter. Hilton Head Capital Partners LLC now owns 336 shares of the medical instruments supplier's stock valued at $43,000 after buying an additional 115 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new stake in ICU Medical in the second quarter worth about $51,000. Finally, Rockefeller Capital Management L.P. boosted its holdings in ICU Medical by 21.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier's stock worth $117,000 after acquiring an additional 146 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and critical care. Its products support the delivery of medications, fluids, and nutrition while helping healthcare providers reduce the risk of complications associated with intravenous treatment.

The company's product portfolio includes infusion pumps and related administration sets, needle-free connectors, vascular access devices, intravenous systems, and other products used in hospitals and alternate-care settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.